| 查看: 298 | 回复: 2 | ||
[求助]
寻找文献
|
|
Pathogenesis and treatment of vascular cognitive impairment. Jellinger KA. Neurodegener Dis Manag. 2014 Dec;4(6):471-90. doi: 10.2217/nmt.14.37. 谢谢啦。。。。 |
回复此楼» 猜你喜欢
285化工学硕求调剂（081700）
已经有10人回复
-
求材料调剂
已经有10人回复
-
本科郑州大学物理学院，一志愿华科070200学硕，346求调剂
已经有4人回复
-
国自科面上基金字体
已经有8人回复
-
能源材料化学课题组招收硕士研究生8-10名
已经有11人回复
-
材料专硕英一数二306
已经有5人回复
-
085600材料与化工调剂 324分
已经有9人回复
-
0703化学调剂
已经有12人回复
-
0703化学 305求调剂
已经有4人回复
-
0703化学调剂，求各位老师收留
已经有10人回复
|
Neurodegener Dis Manag. 2014 Dec;4(6):471-90. doi: 10.2217/nmt.14.37. Pathogenesis and treatment of vascular cognitive impairment. Jellinger KA. Abstract SUMMARY Vascular cognitive impairment (VCI) defines a continuum of disorders ranging from mild cognitive impairment to full-blown dementia, attributable to cerebrovascular causes. Major morphological types - multi-infarct encephalopathy, strategic infarct type, subcortical arteriosclerotic leukoencephalopathy, multilacunar state, postischemic encephalopathy - result from systemic, cardiac and local large or small vessel disease. Cognitive decline is commonly caused by widespread small cerebrovascular lesions (CVLs) affecting regions/networks essential for cognition, memory and behavior. CVLs often coexist with Alzheimer-type and other pathologies, which interact in promoting dementia, but in many nondemented elderly individuals, mixed brain pathologies are also present. Due to the high variability of CVLs, no validated clinical and neuropathological criteria for VCI are available. Cholinesterase inhibitors and memantine produce small cognitive improvement but without essential effect. Antihypertensive treatment, cardiovascular control and lifestyle modifications reducing vascular risk factors are essential. Given its growing health, social and economic burden, prevention and treatment of VCI are a major challenge of neuroscience. KEYWORDS: cerebrovascular lesions; large and small vessel disease; neuropathology; pathogenic factors; prevention and therapeutics; subcortical vascular lesions; vascular cognitive impairment PMID: 25531689 [PubMed - in process] Share on FacebookShare on TwitterShare on Google+ |
2楼2014-12-30 19:51:35
3楼2014-12-30 20:00:56
50